UB Paderborn / Katalog / Suche / in CDI

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG study in 380 patients

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000333

2020

Volltextzugriff (PDF)

Comparison between cold plasma, electrochemotherapy and combined therapy in a melanoma mouse model

Experimental dermatology, 2013-09, Vol.22 (9), p.582-586

2013

Volltextzugriff (PDF)

A key role of GARP in the immune suppressive tumor microenvironment

Oncotarget, 2016-07, Vol.7 (28), p.42996-43009

2016

Volltextzugriff (PDF)

Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1−/− mice

Neurobiology of aging, 2012, Vol.33 (1), p.200.e11-200.e22

2012

Volltextzugriff (PDF)

Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

Nature reviews. Cancer, 2013-05, Vol.13 (5), p.365

2013

Volltextzugriff (PDF)

Personalized medicine

Hautarzt, 2019-01, Vol.70 (1), p.4-4

2019

Volltextzugriff (PDF)

Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis

Trends in immunology, 2016-06, Vol.37 (6), p.364-374

2016

Volltextzugriff (PDF)

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Nature (London), 2012-10, Vol.490 (7420), p.412-416

2012

Volltextzugriff (PDF)

Live or Let Die: T Cell Survival in Cancer Immunotherapy

Immunity (Cambridge, Mass.), 2019-02, Vol.50 (2), p.280-282

2019

Volltextzugriff (PDF)

An IFN-Associated Cytotoxic Cellular Immune Response against Viral, Self-, or Tumor Antigens Is a Common Pathogenetic Feature in “Interface Dermatitis”

Journal of investigative dermatology, 2008-10, Vol.128 (10), p.2392-2402

2008

Volltextzugriff (PDF)

Tissue-resident memory CD8 + T cells promote melanoma-immune equilibrium in skin

Nature (London), 2019-01, Vol.565 (7739), p.366-371

2019

Volltextzugriff (PDF)

Regulatory T cells get nervous in the melanoma microenvironment

Pigment cell and melanoma research, 2013-07, Vol.26 (4), p.434-435

Tueting, Thomas

2013

Volltextzugriff (PDF)

Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing

Immunity (Cambridge, Mass.), 2013-09, Vol.39 (3), p.482-495

2013

Volltextzugriff (PDF)

Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis

International journal of molecular sciences, 2019-11, Vol.20 (23), p.6005

2019

Volltextzugriff (PDF)

The aryl hydrocarbon receptor promotes inflammation‐induced dedifferentiation and systemic metastatic spread of melanoma cells

International journal of cancer, 2020-11, Vol.147 (10), p.2902-2913

2020

Volltextzugriff (PDF)

T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients

Pigment cell and melanoma research, 2013-07, Vol.26 (4), p.441-456

Tüting, Thomas

2013

Volltextzugriff (PDF)

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

Journal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.275-275, Article 275

2024

Volltextzugriff (PDF)

How neutrophils promote metastasis

Science (American Association for the Advancement of Science), 2016-04, Vol.352 (6282), p.145-146

2016

Volltextzugriff (PDF)

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Nature Medicine, 2014-11, Vol.20 (11), p.1301-1309

2014

Volltextzugriff (PDF)

The experimental power of FR900359 to study Gq-regulated biological processes

Nature communications, 2015-12, Vol.6 (1), p.10156, Article 10156

2015

Volltextzugriff (PDF)

CD4 + T cell-induced inflammatory cell death controls immune-evasive tumours

Nature (London), 2023-06, Vol.618 (7967), p.1033-1040

2023

Volltextzugriff (PDF)

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (17), p.4697-4709

2017

Volltextzugriff (PDF)

Differential role of cannabinoids in the pathogenesis of skin cancer

Life sciences (1973), 2015-10, Vol.138, p.35-40

2015

Volltextzugriff (PDF)

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2543-2551

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG study in 380 patients

Comparison between cold plasma, electrochemotherapy and combined therapy in a melanoma mouse model

A key role of GARP in the immune suppressive tumor microenvironment

Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1−/− mice

Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

Personalized medicine

Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Live or Let Die: T Cell Survival in Cancer Immunotherapy

An IFN-Associated Cytotoxic Cellular Immune Response against Viral, Self-, or Tumor Antigens Is a Common Pathogenetic Feature in “Interface Dermatitis”

Tissue-resident memory CD8 + T cells promote melanoma-immune equilibrium in skin

Regulatory T cells get nervous in the melanoma microenvironment

Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing

Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis

The aryl hydrocarbon receptor promotes inflammation‐induced dedifferentiation and systemic metastatic spread of melanoma cells

T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients

Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

How neutrophils promote metastasis

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

The experimental power of FR900359 to study Gq-regulated biological processes

CD4 + T cell-induced inflammatory cell death controls immune-evasive tumours

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

Differential role of cannabinoids in the pathogenesis of skin cancer

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

Suchergebnisse filtern